Overview

Lactobacillus Reuteri Feasibility Study on Probiotic Treatment and Perinatal Microbiome

Status:
Completed
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
Investigators want to investigate if the Lactobacillus Reuteri (probiotic bacteria) given to pregnant women can be found in different maternal compartments and in the first stool and oral swab collected immediately after birth of a newborn delivered by cesarean delivery. Investigators also want to explore if exposure to this Lactobacillus Reuteri alters the level of inflammation in different compartments of the mother and the infant.
Phase:
N/A
Details
Lead Sponsor:
Sahlgrenska University Hospital, Sweden
Collaborator:
BioGaia AB